The high cost of insulin has been a significant concern in the United States for years. Millions of people depend on this life-saving medication, yet its price continues to rise, putting a heavy financial burden on patients with diabetes. Recently, the Federal Trade Commission (FTC) took action, filing a lawsuit against prescription middlemen, accusing them […]
Recent data from a new ASHP (American Society of Health-System Pharmacists) report reveals an intriguing trend in prescription medication spending across the United States. While the overall national expenditure experienced a significant surge, increasing by 13.5% from 2022 to 2023 and totaling a staggering $722.5 billion, this growth was not mirrored in hospital pharmacy spending.
Rise in Medication Spending Not Reflected in Hospital Pharmacies Read More »
To address rising concerns over prescription medication costs, bipartisan lawmakers have introduced a bill to regulate pharmacy benefit managers (PBMs). This legislation aims to bring transparency and accountability to an industry criticized for driving up medication costs in the United States. The Role of Pharmacy Benefit Managers Pharmacy benefit managers act as intermediaries between insurance
Lawmakers Introduce Bipartisan Bill to Crack Down on Medication Middlemen Read More »
In a significant legal development, the 5th Circuit Court partially affirmed a ruling that deemed the Preventive Services Task Force unconstitutional. This task force is responsible for determining the coverage of certain preventive services under the Affordable Care Act (ACA). Additionally, the appellate court upheld the grant of injunctive relief for the plaintiffs in the
U.S. Court of Appeals Partially Affirms Ruling on Preventive Services Task Force Read More »
The market for anti-obesity medications is experiencing unprecedented growth, with some analysts estimating it could become a $100 billion industry by the end of the decade. This surge is largely driven by the popularity of GLP-1 receptor agonists, such as Ozempic and Wegovy, which have shown remarkable efficacy in weight loss. Companies like Calibrate, Ro,
The Booming Market for Anti-Obesity Medications: Opportunities and Challenges Read More »
April 2nd marks a significant step in the ongoing battle against medication shortages as the U.S. Department of Health and Human Services (HHS) releases a comprehensive white paper addressing the issue head-on. Medication shortages have plagued the nation’s healthcare system for decades, primarily due to market failures and misaligned incentives. With the release of this
HHS White Paper Proposes Solutions to Mitigate Medication Shortages Read More »
Observed annually around March 10th to March 16th, Patient Safety Awareness Week serves as a reminder of the critical importance of safety in healthcare. At Atlantic Biologicals, this week holds special significance as we reaffirm our commitment to quality and safety in pharmaceutical distribution. Patient Safety Awareness Week aims to foster crucial conversations and catalyze
Atlantic Biologicals: Prioritizing Patient Safety Read More »
The pharmaceutical distribution landscape faces challenges in the wake of dramatic margin fluctuations and financial struggles within the hospital sector. As we enter 2024, Atlantic Biologicals, emerges as a steadfast partner, navigating the complex terrain of the healthcare industry. Understanding the Pharmaceutical Distribution Landscape 2022 marked one of the worst financial years for hospitals in
Atlantic Biologicals Stands Strong Amidst Healthcare Sector’s Turbulence Read More »
Atlantic Biologicals is a premier distributor of brand, generic and critical care pharmaceuticals. We service hospitals, physicians’ offices, oncology clinics, diagnostic centers, freestanding clinics, and home infusion facilities.
Sign up to receive email updates on announcements, sales, promotions, and more !
